SEOUL, April 11 (Bloomberg): South Korea will resume AstraZeneca Plc’s Covid-19 vaccine inoculations for those between the ages of 30 and 60 years as its health authorities balanced potential risks of the shots against a widening outbreak.
The Asian nation temporarily suspended the use of the vaccine for those below 60 last week after a 20-year-old health care worker was diagnosed with a blood clot shortly after getting an Astra dose. It followed similar blood clot reports elsewhere, prompting dozens of countries to limit Astra use.